Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereof
US10786480B2 · kind B2 · utility
1Cited by
18References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 24, 2019 |
| Grant date | Sep 29, 2020 |
| Priority date | — |
| Expiry date | Apr 24, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods and pharmaceutical compositions for treating proliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.